Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients

• Main Authors: Li, F.-F, Liu, B.-L, Yin, G.-P, Zhang, D.-F, Zhai, X.-F, Chen, M.-Y, Su, X.-F, Wu, J.-D, Ye, L, Ma, J.-H
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: antidiabetic agent; biological marker; insulin; metformin; adult; blood; combination drug therapy; female; glucose blood level; human; male; middle aged; non insulin dependent diabetes mellitus; onset age; randomized controlled trial (topic); treatment outcome; Adult; Age of Onset; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178297
• Institution: National University of Singapore

10.1038/s41598-017-16658-x